Comparing Bortezomib-Lenalidomide-Dexamethasone (Vrd) With Carfilzomiblenalidomide-Dexamethasone (Krd) In The Patients With Newly Diagnosed Multiple Myeloma (Ndmm) In Two Observational Studies
BLOOD（2018）
摘要
Background
更多查看译文
关键词
multiple myeloma,bortezomib-lenalidomide-dexamethasone,carfilzomib-lenalidomide-dexamethasone
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要